Discover key insights from MSA Safety's Q2 2025 earnings call—including growth in Detection, pricing impacts, and the M&C TechGroup acquisition.

Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling ...

Discover key insights from Encompass Health's Q2 2025 earnings call, including 12% revenue growth, raised guidance, and expansion plans.

What To Know: The company reported sales of $544.83 million, missing the consensus estimate of $549.82 million, but representing a 73% year-over-year increase. In addition, the company reported ...

A new 50% tariff on Brazilian coffee imports could squeeze Starbucks' margins and force the company to rethink its supply ...

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

Q2 2025 Management View William C. Cobb, Chairman and CEO, reported that "revenue increased 14% year-over-year to $617 million" and gross margin improved to 58%. Cobb stated, "Net income grew 21% to ...